DiaMedica Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $-27 | $0 | $0 |
Gross Profit | -11 | -13 | -18 | -3 |
EBITDA | -10,024 | -8,719 | -8,596 | -7,690 |
EBIT | -10,035 | -8,730 | -8,614 | -7,693 |
Net Income | -10,042 | -8,740 | -8,620 | -7,699 |
Net Change In Cash | 0 | -27 | 0 | 0 |
Free Cash Flow | -9,090 | -7,771 | -6,621 | -7,604 |
Cash | 4,868 | 15,647 | 3,326 | 4,109 |
Basic Shares | 53,793 | 46,980 | 49,630 | 42,957 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -30 | -25 | |
EBITDA | -32,695 | -24,375 | -19,308 | -13,623 |
EBIT | -32,738 | -24,414 | -19,338 | -13,648 |
Net Income | -32,766 | -24,444 | -19,381 | -13,676 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,102 | -22,101 | -18,752 | -11,592 |
Cash | 15,647 | 3,025 | 4,543 | 4,728 |
Basic Shares | 46,980 | 40,404 | 32,566 | 26,443 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.16 |
2025-12-31 | -$0.17 |
2025-09-30 | -$0.17 |
2025-06-30 | -$0.18 |